Procurement and formulation teams sourcing decamethylcyclopentasiloxane (D5) are confronting a specification landscape that has shifted decisively from performance-driven to compliance-driven. With the EU’s REACH Annex XVII Entry 70 restriction taking effect on 6 June 2026, the selection logic for CAS#541-02-6 is no longer merely about volatility, spreadability, or sensory profile. It is now a question of whether the material—or the formulation containing it—can legally remain on the European market at all.
The Grade Matrix: Industrial, Cosmetic, and the Purity Gap That Matters
Commercial D5 is not a single specification. Suppliers differentiate primarily by purity and application suitability. Standard industrial-grade material typically targets ≥98.5% D5 content, with octamethylcyclotetrasiloxane (D4) capped at ≤0.2% and total other methylcyclosiloxanes at ≤1.5%. Cosmetic-grade material demands tighter control on residual cyclic siloxanes, given the regulatory exposure of D4 and D6 as co-restricted substances. Laboratory-grade offerings from major suppliers specify GC purity of ≥96.5% to ≥97%, with refractive index and infrared spectrum conformity as release criteria.
The critical selection variable for 2026 and beyond is the D4 and D6 residual profile, not the D5 assay itself. The EU restriction applies to each substance individually at a 0.1% (1,000 ppm) threshold in mixtures. A D5 grade that meets 98.5% assay but carries 0.15% D4 becomes non-compliant the moment it enters a leave-on cosmetic formulation destined for the EU. Buyers should require supplier COAs to report D4, D5, and D6 individually, with batch-level traceability rather than typical values.
Regulatory Countdown: The Dates That Reshape Supply
The REACH restriction timeline is staggered, and the differentiation is operationally significant. From 6 June 2026, D4, D5, and D6 cannot be placed on the EU market as substances, constituents of other substances, or in mixtures at concentrations ≥0.1% by weight. This is the general industrial deadline. For leave-on cosmetic products—the largest historical outlet for D5—the restriction applies from 6 June 2027. Wash-off cosmetics have been restricted since January 2020 and are already reformulated in most EU-compliant supply chains. Medical devices and medicinal products have a derogation until 6 June 2031, and D5 as a dry-cleaning solvent until 2034, subject to closed-system conditions.
Industrial exemptions exist and deserve attention from procurement teams sourcing D5 for non-cosmetic uses. The restriction does not apply to D5 placed on the market as a monomer in silicone polymer production, as an intermediate in the manufacture of other silicon substances, in polymerisation, in the formulation or repacking of mixtures for industrial uses, or as a laboratory reagent under controlled conditions. For formulators, this means the compliance question is application-specific: a D5 lot destined for silicone polymer synthesis follows a different regulatory pathway than the same lot destined for a skin-care emulsion.
Formulation Reality: D5 Is Difficult to Replace One-for-One
The technical case for D5 remains intact even as the regulatory case narrows. ECHA’s own assessment notes that D5 functions as a hair-conditioning agent, skin-conditioning emollient, and solvent/diluent, providing smooth spreading and a silky, non-greasy after-feel due to its high volatility. Reported maximum concentrations in leave-on hair care reached 95% in some product categories, with leave-on skin care and makeup reaching 90%. These are not trivial loadings.
Asia-Pacific formulators have been evaluating alternatives since early 2025, but the market signal is clear: no single replacement reproduces D5’s combination of volatility, spreadability, and lightweight sensory profile. Formulators are instead testing blends of alternative volatile silicones, non-silicone emollients, and specialty materials to approximate the consumer-perceived benefits. For procurement teams, this implies that D5 contracts should be paired with qualification programs for alternative systems—not because D5 is disappearing globally, but because EU-destined SKUs cannot rely on it beyond the applicable deadline.
Supplier Qualification: What to Ask Beyond the COA
Given the regulatory stakes, supplier selection for CAS#541-02-6 should include documentation that most standard COAs do not carry. Request the full cyclic siloxane distribution (D4, D5, D6, and where relevant D3) on a batch basis, not a certificate of analysis with “typical” values. Confirm whether the supplier can provide material consistently below 0.1% D4 and D6 for cosmetic-grade applications—some Chinese producers have already announced D4/D5/D6 <0.1% product lines with REACH registration. For industrial exemptions, obtain a written statement of the intended downstream use and the corresponding REACH derogation pathway, because the compliance burden shifts to the formulator placing the mixture on the market.
Packaging and logistics specifications also warrant review. D5 is typically supplied in steel drums (190 kg net) or ISO tanks (950 kg net), with storage requirements excluding oxidants, acids, and alkalis. Flash point is reported at 73°C, and hazardous polymerisation may occur under certain conditions. These are standard handling parameters, but they matter for facilities that may be transitioning D5 storage to segregated areas as volumes decline in EU-compliant formulations.
Market Outlook: Regional Divergence, Not Global Disappearance
The D5 market is not collapsing; it is redistributing. Asia-Pacific remains the dominant manufacturing base for cosmetics and personal care, and D5 continues to serve established applications where local regulations permit. China, Japan, South Korea, and Southeast Asian markets support ongoing formulation activity, though international brands are increasingly applying global ingredient policies across regional operations. Industrial-grade D5 for silicone polymer synthesis and non-cosmetic applications remains outside the EU restriction’s core scope, preserving a baseline demand floor.
The procurement implication is straightforward: D5 sourcing strategies should be segmented by destination market and application. EU-destined cosmetic SKUs require either reformulation away from D5 or reliance on the 2027 derogation for leave-on products with a defined exit timeline. Industrial and non-EU applications can continue with conventional grade selection, but with COA requirements tightened to capture the cyclic siloxane profile that regulators now scrutinize.
Selection Checklist
Specify D4 and D6 limits, not just D5 assay. Require batch-level reporting of all three restricted cyclosiloxanes against the 0.1% threshold.
Match grade to regulatory pathway. Cosmetic-grade for leave-on products must clear the 2027 deadline; industrial-grade for polymer synthesis may qualify for derogation.
Verify REACH registration status. For EU-destined material, confirm the supplier’s registration covers the intended use and that documentation supports the exemption claimed.
Qualify alternatives in parallel. D5’s sensory profile is not easily replicated; begin blend qualification before the compliance deadline forces reformulation under time pressure.
